Home / Knowledge Centre /
Poster

Platinum-based therapy selects for an angiogenic enriched tumour micro-environment in High Grade Serous Ovarian Cancer

Download Almac Diagnostic Services Poster Presentation on ‘Platinum-based therapy selects for an angiogenic enriched tumour micro-environment in High Grade Serous Ovarian Cancer’.

Conclusion:
1. The clinical and pre-clinical data discussed has potentially significant clinical implications in the management of treatment-relapsed HGSOC
2. Platinum-resistance (innate and acquired) in relapsed HGSOC is an indicator for response to anti-angiogenics
3. We have found that relapse post platinum-therapy in HGSOC is associated with an angiogenic biology
4. This clinical and pre-clinical data supports the use of anti-angiogenic agents in the first and second line setting in patients with innate and acquired resistance to platinum therapy, respectively

View Resource
Almac Logo

Diagnostic Services

Your global partner for biomarker discovery, development & commercialisation.

Genomic Services

We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.

Clinical Trial Assays

Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.

Companion Diagnostics

A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialisation services.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies